Relevance of Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture protocol to "Select a DNA pathogen-identification workflow for diagnostic testing"
- Use case
- Select a DNA pathogen-identification workflow for diagnostic testing
- Assessed by
- Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture protocol
- Relevance
- Proxy evidence
- Endpoint
- Positive percent agreement with initial blood culture for plasma microbial cfDNA sequencing in a prospective sepsis-alert cohort (59/63 initial-blood-culture-positive subset)
Positive percent agreement against initial blood culture is a proxy for sensitivity against all true infections, since initial blood culture does not identify every infection.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
15 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Positive percent agreement with initial blood culture for plasma microbial cfDNA sequencing in a prospective sepsis-alert cohort (59/63 initial-blood-culture-positive subset) Context-only references | Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:amp-20261007-dna-pathogens-protocol Context-only references | Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations5 values
| Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records5 values
| Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale Positive percent agreement against initial blood culture is a proxy for sensitivity against all true infections, since initial blood culture does not identify every infection. Context-only references | Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Reason Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365). Context-only references | Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relevance proxy Context-only references | Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Revision 1 Context-only references | Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source · Original source · Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Technical metadata and extraction receipts
Stable ID: use-case-mapping-amp-20261007-issue13
- field
- links:assessed_by:amp-20261007-dna-pathogens-protocol
- value
- amp-20261007-dna-pathogens-protocol
- relevance
- proxy
- endpoint
- Positive percent agreement with initial blood culture for plasma microbial cfDNA sequencing in a prospective sepsis-alert cohort (59/63 initial-blood-culture-positive subset)
- rationale
- Positive percent agreement against initial blood culture is a proxy for sensitivity against all true infections, since initial blood culture does not identify every infection.
- constraints
- Inspect every linked evaluation's source locator and preserved conflicts before citing a result.; Do not combine this mapping's evaluations with any other protocol's results.
- limitations
- Positive agreement uses initial blood culture as reference, which does not identify all infections. It is not sensitivity against all true infections.; Exact executable/software/database revision is not established; no foundation model and no new execution.; Composite-reference outcomes and estimates are separate endpoints; Table 2 negative composite CI54.8–70.0 conflicts with narrative55.2–70.4 and is excluded.; DNA-only plasma microbial cfDNA assay; no RNA viral detection or RNA sensitivity implied.; Primary article hosted on third-party rious168 mirror; DOI/title match publisher. Public redistribution licence absent; only compact factual table excerpt retained, original PDF retrieval hash preserved.
- revision
- 1
- reason
- Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365).
- citation locators
- source id: amp-20261007-dna-pathogens-source; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- source locator
- amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- review
- method: automated-source-review; reviewer: codex; claude-sonnet; reviewer note: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values; independently reviewed by Codex (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); reviewed at: 2026-10-07T13:38:59Z; note: Bounded primary-source transcription, independently Codex-checked. No new model execution, independent experimental reproduction, qualified human scientific review or clinical validation.
- reviewed evaluations
- amp-20261007-dna-pathogens-evaluation
- pins
- record id: amp-20261007-dna-pathogens-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: ce8617fbc13f8282b5e955f0d7cef8eb3251a97486ebaea814c4af52e32361eb; record id: amp-20261007-dna-pathogens-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: 9adcc42991495a454d89c8419779e9011fb7adf847dd162fde7fd4c8bb515f42; record id: amp-20261007-dna-pathogens-result; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: ecf440edaaa50989e51c19ebf3a60de36b70dc82038b5a19064e6898c9ad6b20; record id: amp-20261007-dna-pathogens-source; fields: status; attributes.artifact_sha256; sha256: a104308fb7c3a4f95e415764d658fabf6744207f0197bcc9ad06959a9039fb65; record id: use-case-diagnostic-dna-pathogen-identification; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: fc133441f475bb23dafd0c0c55f4e16cd20302f9148b21b98de31077dfe16338